Crossmark

Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes

Crossref DOI link: https://doi.org/10.1186/s13053-018-0102-4

Published Online: 2019-01-23

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Henn, Jonas

Spier, Isabel http://orcid.org/0000-0003-2407-7427
Adam, Ronja S.

Holzapfel, Stefanie

Uhlhaas, Siegfried

Kayser, Katrin

Plotz, Guido

Peters, Sophia

Aretz, Stefan
License Information

Text and Data Mining valid from 2019-01-23
More Information

Article History

Received: 7 September 2018

Accepted: 12 December 2018

First Online: 23 January 2019

Ethics approval and consent to participate

: The patients provided informed consent to genetic diagnostics to identify the cause of the suspected HTS.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.